Translational pharmacokinetic (PK), pharmacodynamic (PD) modeling and simulation analysis of MetMAb

被引：1
|
作者：
Bender, B. [1 ]
Xiang, H. [2 ]
Reyes, A. E., II [2 ]
Damico, L. A. [2 ]
Merchant, M. [3 ]
Peterson, A. [4 ]
Forrest, W. [5 ]
Jumbe, N. L. [1 ]
机构：
[1] Genentech Inc, Clin PKIPD, San Francisco, CA USA
[2] Genentech Inc, Early Dev PKIPD, San Francisco, CA USA
[3] Genentech Inc, Translat BioOncol, San Francisco, CA USA
[4] Genentech Inc, Clin BioOncol, San Francisco, CA USA
[5] Genentech Inc, NonClin Biostat, San Francisco, CA USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72473-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [31] Translational Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling Strategy to Support RG6042 Dose Selection in Huntington's Disease (HD)
    Ducray, Patricia Sanwald
    Frances, Nicolas
    Smart, Kevin
    Norris, Dan
    Kordasiewicz, Holly
    Guenther, Andreas
    Wild, Edward
    Schobel, Scott
    NEUROLOGY, 2019, 92 (15)
  • [32] Translational PK–PD modeling in pain
    Ashraf Yassen
    Paul Passier
    Yasuhisa Furuichi
    Albert Dahan
    Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40 : 401 - 418
  • [33] Pharmacokinetic (PK) and pharmacodynamic (PD) correlation in topical drug formulation
    Lenn, J.
    Aloor, H.
    Cote-Sierra, J.
    Santos, L.
    Cook, S.
    Therrien, J.
    Hofland, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S39 - S39
  • [34] Pharmacokinetic (PK) pharmacodynamic (PD) model of FTY 720 in humans
    Marino, M
    Choudhury, S
    Neumayer, HH
    Brunkhorst, R
    Lucker, P
    Brookman, L
    Schmouder, R
    TRANSPLANTATION, 1999, 67 (07) : S205 - S205
  • [35] Pharmacokinetic (PK) and pharmacodynamic (PD) relationships for intranasal corticosteroids (INCS)
    Daley-Yates, PT
    Richards, DH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S313 - S313
  • [36] Gender modulates the pharmacokinetic/pharmacodynamic (PK/PD) of metoprolol.
    Sharma, A
    Pilote, S
    Pibarot, P
    Jobin, J
    Dumesnil, JG
    Arseneault, A
    Hamelin, BA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P70 - P70
  • [37] Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling and Trial Simulation for Selection of Optimal Dose of Fedratinib (SAR302503)
    Liu, Li
    Xu, Christine
    Su, Yaming
    Ma, Lei
    Quan, Hui
    Kanamaluru, Vanaja
    Shun, Zhenming
    Deutsch, Paul
    Zaks, Tal
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S18 - S18
  • [38] POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING OF DEPOT TESTOSTERONE CYPIONATE IN HEALTHY MALE SUBJECTS
    Bi, Y.
    Murry, D.
    Ellerby, M.
    Perry, P. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S80 - S81
  • [39] The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics
    Agoram, Balaji M.
    Martin, Steven W.
    van der Graaf, Piet H.
    DRUG DISCOVERY TODAY, 2007, 12 (23-24) : 1018 - 1024
  • [40] Dosing Evaluation of Ceftazidime-Avibactam in Intensive Care Unit Patients Based on Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling and Simulation
    Zazo, Hinojal
    Aguazul, Yuridia
    Lanao, Jose M.
    ANTIBIOTICS-BASEL, 2024, 13 (09):
12345